atezolizumab,xl092
exelixis,roche
['solid tumor', 'xl092', 'xl092 ', 'stellar-001', 'exelixis']
exelixis announces dose-escalation results from the phase 1 stellar-001 trial evaluating xl092 alone and in combination with an immune checkpoint inhibitor in patients with advanced solid tumors at esmo 2022 - 
MD MSC CPDS https://t.co/kePCRsvthW  https://t.co/t7oxnCDRg8  #cardiology  #AI #informatics #healthcare #innovation #entrepreneur RSS feeds